文献速递青光眼

低成本青光眼引流装置(Aurolab房水引流植入物)与Ahmed青光眼阀的长期结局比较

Long-term outcome of low-cost glaucoma drainage device (Aurolab aqueous drainage implant) compared with Ahmed glaucoma valve.
PubMed 文献 · Br J Ophthalmol · 2019-07-04

回顾性分析比较了Aurolab房水引流植入物(AADI)与Ahmed青光眼阀(AGV)在难治性青光眼患者中的长期结局。AADI组在术后2年内各时间点眼压均显著低于AGV组,3年时两组眼压相当;AADI组术后3年内抗青光眼药物用量显著更少。两组手术安全性相似,AADI组低眼压相关并发症略多但无统计学意义。

要点

  • AADI组术后2年内各时间点眼压均显著低于AGV组,3年时两组眼压相当。
  • AADI组术后3年内抗青光眼药物数量显著少于AGV组。
  • 3年时AADI组完全成功率25.00%显著高于AGV组7.27%(p=0.02)。

核心结论

  • AADI与AGV植入物在3年时平均眼压相当,AADI组抗青光眼药物需求更少。
  • 两种手术均看似安全,AADI组低眼压相关并发症略多。

研究设计与样本

  • 回顾性分析纳入接受AGV(AGV-FP7)或AADI(AADI Model 350)植入的难治性青光眼患者。
  • AGV组173例患者(189眼),AADI组201例患者(206眼)。
  • 结局指标为眼压、抗青光眼药物需求及为控制眼压的再手术;并发症按早期(≤3个月)、中期(>3个月至≤1年)和晚期(>1年)分类。

主要发现

  • AADI组眼压在术后2年内所有时间点均显著低于AGV组,3年时两组相当。
  • AADI组术前抗青光眼药物数量显著多于AGV组,术后3年内显著少于AGV组。
  • AADI组低眼压相关并发症多于AGV组,但差异无统计学意义(p=0.07)。
  • 晚期术后手术干预AGV组(n=18)显著多于AADI组(n=5)(p=0.01)。
  • 3年时总体成功率AGV组58.18% vs AADI组73.08%(p=0.15),完全成功率AGV组7.27% vs AADI组25.00%(p=0.02)。

关键数值与推荐

  • 3年总体成功率:AGV组58.18% vs AADI组73.08%(p=0.15)。
  • 3年完全成功率:AGV组7.27% vs AADI组25.00%(p=0.02)。
  • 晚期手术干预:AGV组n=18 vs AADI组n=5(p=0.01)。
  • 低眼压相关并发症组间比较p=0.07。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the long-term outcome of Aurolab aqueous drainage device (AADI) and Ahmed glaucoma valve (AGV). METHOD: Retrospective analysis of patients with refractory glaucoma who underwent AGV (AGV-FP7) and AADI (AADI Model 350) implantation. The outcome measures were intraocular pressure (IOP), requirement of antiglaucoma medications (AGMs) and re-surgery for IOP control. The postoperative complications were classified as early (≤3 months), intermediate (>3 months to ≤1 year) or late (>1 year). RESULTS: 173 patients (189 eyes) underwent AGV implantation (AGV Group) while 201 patients (206 eyes) underwent AADI implantation (AADI group). The IOP in AADI group was significantly lower than AGV group at all time points till 2 years and comparable at 3 years. AADI group had significantly higher number of AGM in preoperative period and significantly lower number in postoperative period till 3 years compared with AGV group. AADI group had more hypotony-related complications but statistically insignificant (p = 0.07). The surgical interventions were significantly higher in AGV (n = 18) compared with AADI group (n = 5) in late postoperative period (p = 0.01). At 3 years, overall success was seen in 58.18% in AGV and 73.08% in AADI group (p = 0.15). Complete success was seen in 7.27% patients in AGV and 25.00% patients in AADI group (p = 0.02). CONCLUSION: Both AADI and AGV implant had comparable mean IOP at 3 years with lesser requirement of AGM in the AADI group. Both procedures appear to be safe with slight preponderance of hypotony-related complications in AADI group.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pandav SS, Seth NG, Thattaruthody F, et al. Long-term outcome of low-cost glaucoma drainage device (Aurolab aqueous drainage implant) compared with Ahmed glaucoma valve. Br J Ophthalmol. 2019. PMID: 31272955. doi:10.1136/bjophthalmol-2019-313942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。